Emergent Biosolutions EBS Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's other intangible assets—net?
- Emergent Biosolutions (EBS) reported other intangible assets—net of $470.4M in Q1 2026.
- How has Emergent Biosolutions's other intangible assets—net changed year-over-year?
- Emergent Biosolutions's other intangible assets—net decreased by 3.1% year-over-year, from $485.2M to $470.4M.
- What is the long-term trend for Emergent Biosolutions's other intangible assets—net?
- Over 5 years (2020 to 2025), Emergent Biosolutions's other intangible assets—net has grown at a -8.0% compound annual growth rate (CAGR), from $663.1M to $436.5M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.